Randomized Controlled Trial Comparing Transanal Doppler-guided Arterial Ligation With Mucopexy and Stapled Haemorrhoidopexy
NCT ID: NCT01240772
Last Updated: 2014-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
407 participants
INTERVENTIONAL
2010-12-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease
NCT06170736
Doppler-guided Haemorrhoidal Artery Ligation With Suture Mucopexy vs. Suture Mucopexy Alone
NCT02372981
Doppler-guided or Non Doppler-guided Arterial Ligation and Mucopexy for Third Degree Hemorrhoids: That is the Question
NCT03729414
Long-term Efficacy of Doppler Ligation With Mucopexy in the Treatment of Internal Hemorrhoidal Disease
NCT04708678
Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal Disease
NCT04101773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DGALM
doppler-guided arterial ligation with mucopexy
doppler-guided arterial ligation with mucopexy
doppler-guided arterial ligation with mucopexy
SH
stapled haemorrhoidopexy according to Longo
stapled haemorrhoidopexy according to Longo
stapled haemorrhoidopexy according to Longo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
doppler-guided arterial ligation with mucopexy
doppler-guided arterial ligation with mucopexy
stapled haemorrhoidopexy according to Longo
stapled haemorrhoidopexy according to Longo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from symptomatic grade II or III haemorrhoidal disease (bleeding and/or prolapse)
* requiring surgery
Exclusion Criteria
* History of anal surgery for haemorrhoids
* Congenital or acquirred anal stenosis
* Anal fissure or perianal abcess
* Inflammatory bowel disease
* Colon or rectal cancerv History of rectal or sigmoid resection
* Rectal prolapse
* Portal vein hypertension
* Haemophylia
* Pregnancy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angers University Hospital
Angers, , France
Grenoble University Hospital
Grenoble, , France
La Roche/Yon Hospital
La Roche/Yon, , France
Lille University Hospital "Claude Huriez"
Lille, , France
Marseille University Hospital "Hôpital Nord"
Marseille, , France
Marseille University Hospital "La Timone"
Marseille, , France
Nantes University Hospital
Nantes, , France
Niort Hospital
Niort, , France
Nîmes University Hospital
Nîmes, , France
Polyclinic H. MALARTIC
Ollioules, , France
"Institut Mutualiste Montsouris"
Paris, , France
Hopital St Joseph
Paris, , France
Poissy / Saint-Germain en Laye Hospital
Poissy, , France
Rennes University Hospital
Rennes, , France
Saint-Etienne University Hospital
Saint-Etienne, , France
"Pôle Hospitalier Mutualiste"
Saint-Nazaire, , France
Strasbourg University Hospital
Strasbourg, , France
Foch Hospital
Suresnes, , France
Talence Bagatelle Hospital
Talence, , France
Toulouse University Hospital
Toulouse, , France
Tours University Hospital
Tours, , France
Vichy Hospital
Vichy, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Woaye-Hune P, Hardouin JB, Lehur PA, Meurette G, Vanier A. Practical issues encountered while determining Minimal Clinically Important Difference in Patient-Reported Outcomes. Health Qual Life Outcomes. 2020 May 27;18(1):156. doi: 10.1186/s12955-020-01398-w.
Venara A, Podevin J, Godeberge P, Redon Y, Barussaud ML, Sielezneff I, Queralto M, Bourbao C, Chiffoleau A, Lehur PA; LigaLongo Study Group. A comparison of surgical devices for grade II and III hemorrhoidal disease. Results from the LigaLongo Trial comparing transanal Doppler-guided hemorrhoidal artery ligation with mucopexy and circular stapled hemorrhoidopexy. Int J Colorectal Dis. 2018 Oct;33(10):1479-1483. doi: 10.1007/s00384-018-3093-8. Epub 2018 May 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDRCB 2010-A00642-37
Identifier Type: OTHER
Identifier Source: secondary_id
STIC/10/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.